Literature DB >> 19906222

Human milk oligosaccharides: prebiotics and beyond.

Lars Bode1.   

Abstract

Human milk oligosaccharides (HMO) are complex glycans that are present at very high concentrations in human milk but not in infant formula. The significant energy expended by mothers to make these complex glycans suggests they must be important. How do maternal HMOs benefit the breast-fed infant? How are HMOs synthesized in the human mammary gland? How can we provide formula-fed infants with HMOs or HMO-like glycans? This article reviews current knowledge and open questions on the biosynthesis and functions of HMOs.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19906222     DOI: 10.1111/j.1753-4887.2009.00239.x

Source DB:  PubMed          Journal:  Nutr Rev        ISSN: 0029-6643            Impact factor:   7.110


  72 in total

1.  The human milk oligosaccharide disialyllacto-N-tetraose prevents necrotising enterocolitis in neonatal rats.

Authors:  Evelyn Jantscher-Krenn; Monica Zherebtsov; Caroline Nissan; Kerstin Goth; Yigit S Guner; Natasha Naidu; Biswa Choudhury; Anatoly V Grishin; Henri R Ford; Lars Bode
Journal:  Gut       Date:  2011-12-03       Impact factor: 23.059

2.  Human milk oligosaccharides protect bladder epithelial cells against uropathogenic Escherichia coli invasion and cytotoxicity.

Authors:  Ann E Lin; Chloe A Autran; Sophia D Espanola; Lars Bode; Victor Nizet
Journal:  J Infect Dis       Date:  2013-08-29       Impact factor: 5.226

3.  Introduction to the symposium.

Authors:  Clemens Kunz; Gyula Dekany; Christoph H Röhrig; Sharon M Donovan
Journal:  Adv Nutr       Date:  2012-05-01       Impact factor: 8.701

4.  An L-Fucose Operon in the Probiotic Lactobacillus rhamnosus GG Is Involved in Adaptation to Gastrointestinal Conditions.

Authors:  Jimmy E Becerra; María J Yebra; Vicente Monedero
Journal:  Appl Environ Microbiol       Date:  2015-03-27       Impact factor: 4.792

5.  Factors influencing the infant gut microbiome at age 3-6 months: Findings from the ethnically diverse Vitamin D Antenatal Asthma Reduction Trial (VDAART).

Authors:  Joanne E Sordillo; Yanjiao Zhou; Michael J McGeachie; John Ziniti; Nancy Lange; Nancy Laranjo; Jessica R Savage; Vincent Carey; George O'Connor; Megan Sandel; Robert Strunk; Leonard Bacharier; Robert Zeiger; Scott T Weiss; George Weinstock; Diane R Gold; Augusto A Litonjua
Journal:  J Allergy Clin Immunol       Date:  2016-10-13       Impact factor: 10.793

6.  Commensal Propionibacterium strain UF1 mitigates intestinal inflammation via Th17 cell regulation.

Authors:  Natacha Colliou; Yong Ge; Bikash Sahay; Minghao Gong; Mojgan Zadeh; Jennifer L Owen; Josef Neu; William G Farmerie; Francis Alonzo; Ken Liu; Dean P Jones; Shuzhao Li; Mansour Mohamadzadeh
Journal:  J Clin Invest       Date:  2017-09-25       Impact factor: 14.808

Review 7.  Synthesis and purification of galacto-oligosaccharides: state of the art.

Authors:  Carlos Vera; Andrés Córdova; Carla Aburto; Cecilia Guerrero; Sebastián Suárez; Andrés Illanes
Journal:  World J Microbiol Biotechnol       Date:  2016-10-18       Impact factor: 3.312

8.  Cryogenic IR spectroscopy combined with ion mobility spectrometry for the analysis of human milk oligosaccharides.

Authors:  Neelam Khanal; Chiara Masellis; Michael Z Kamrath; David E Clemmer; Thomas R Rizzo
Journal:  Analyst       Date:  2018-04-16       Impact factor: 4.616

9.  The human milk oligosaccharide 2'-fucosyllactose attenuates the severity of experimental necrotising enterocolitis by enhancing mesenteric perfusion in the neonatal intestine.

Authors:  Misty Good; Chhinder P Sodhi; Yukihiro Yamaguchi; Hongpeng Jia; Peng Lu; William B Fulton; Laura Y Martin; Thomas Prindle; Diego F Nino; Qinjie Zhou; Congrong Ma; John A Ozolek; Rachael H Buck; Karen C Goehring; David J Hackam
Journal:  Br J Nutr       Date:  2016-09-09       Impact factor: 3.718

10.  Perspective: Structure-Function Claims on Infant Formula.

Authors:  John C Wallingford
Journal:  Adv Nutr       Date:  2018-05-01       Impact factor: 8.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.